Funding for this research was provided by:
Austin Medical Research Foundation (Not applicable)
National Health and Medical Research Council (1073378, 1923526)
Australian Society for Antimicrobials (Not applicable)
Received: 19 July 2017
Accepted: 22 February 2018
First Online: 5 March 2018
: The following are members of the steering committee for the VANESSA (VANcomycin Efficacy in Staphylococcal Sepsis in Australasia) study: Natasha E. Holmes (Austin Health), Paul D. R. Johnson (Austin Health), Benjamin P. Howden (Austin Health), John D. Turnidge (Women’s and Children’s Hospital), J. Owen Robinson (Royal Perth Hospital), Sebastian J. van Hal (Liverpool Hospital, Royal Prince Alfred Hospital), Wendy J. Munckhof (Princess Alexandra Hospital), Eugene Athan (Barwon Health), Tony M. Korman (Monash Health), Allen C. Cheng (Alfred Hospital).
: Human research ethics committee approval was obtained at each of the participating sites (Austin Health H2010/04092, Alfred Hospital 392/10, Barwon Health 10/141, Liverpool Hospital HREC/10/LPOOL/189, Monash Health 10340A, Princess Alexandra Hospital HREC/10/QPAH/296, Royal Prince Alfred Hospital HREC/12/RPAH/290, Royal Perth Hospital 2011/021). Written informed consent was obtained from all participants at all participating sites.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.